Multiple clinical studies have shown that anti-PD-1/PD-L1 therapy has exceedingly significant clinical importance for improving the survival rates of patients with advanced and metastatic tumors.
← all excerpts
Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications.
1
—
—